Pharmagen, Inc. (PHRX)

USD 0.0

(0.0%)

Annual Cash Flows

(In USD)
Breakdown 2013
Operating Cash Flow -692.07
Net Income -6000.61
Depreciation & Amortization 99.35
Deferred income taxes -
Stock-based compensation 120.53
Change in working capital 740.96
Other non-cash items 4347.71
Investing Cash Flow -56.70
Investments in PPE -56.70
Acquisitions -
Investment purchases -
Sales/Maturities of investments -
Other Investing Activities -
Financing Cash Flow 652.20
Debt repayment -562.70
Dividends payments -
Common Stock Repurchased -
Common Stock Issuance -
Other Financing Activities 89.50
Accounts receivables 267.75
Accounts payables -
Inventory 10.40
Other working capital 462.81
Cash at beginning of period 322.56
Cash at end of period 225.98
Capital Expenditure -56.70
Effect of forex changes on cash -
Net cash flow / Change in cash -96.57
Free Cash Flow -748.77

Cash Flow Charts